"Your Big Red Biotech Blog is both good and original; but the part that is good is not original, and the part that is original is not good."
« DSM Cuts New CMO Deal With Aussie Government | Main | Patent Dispute India Heats Up - 90 Challenges by IPA »
05/04/2010
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b0134805d2a5f970c
Listed below are links to weblogs that reference Samuel Johnson paraphrased:
1 Favorite
The comments to this entry are closed.
Recent Posts
- Novartis Hops the Hep C Train
- GAO Report Places Primary Blame on Manufacturing Failures for Drug Shortages
- Gilead Still Liking Its $11B Hep C Deal?
- The Costly Myths about Pharmaceutical R&D
- Shhh! My Bioproduction Processes are Secret
- Not a Good Day for Senior Directors (and others) at Alnylam
- Dwindling R&D Returns?
- Hep C Companies Rumored as Next Takeovers
- Biosimilars are Progressing by the 'Totality of Evidence'
- Biosimilar Guidance Is A Pandora’s Box: Pan Explains
Search
Archives
- February 19, 2012 - February 25, 2012
- February 12, 2012 - February 18, 2012
- February 5, 2012 - February 11, 2012
- January 29, 2012 - February 4, 2012
- January 22, 2012 - January 28, 2012
- January 15, 2012 - January 21, 2012
- January 8, 2012 - January 14, 2012
- January 1, 2012 - January 7, 2012
- December 25, 2011 - December 31, 2011
- December 18, 2011 - December 24, 2011
Categories
- AIDs
- Animal Health
- Antibody Drug Conjugates
- Brazil News
- Business Model
- Cell Engineering
- China news
- Clinical Results
- CNS Therapies
- Conservative Curmudgeon Palaver
- Current Events
- Development Funding & Investment
- Drug Development
- Economics
- Ethics
- Facility News
- FDA & EU Approvals
- Formulary Boards & 3rd Party Payers
- Gene Therapy
- Generics & Biosimilars
- Government Policy
- Healthcare Reform
- India News
- Innovation
- Korea News
- Liberal Altruisim
- Manufacturing Challenges
- Market Data & Facts & Research
- Market Rumors
- Mergers & Acquisitions
- Oncology
- OpEx and Lean
- Orphan, Neglected & Rare Diseases
- Outsourcing
- Patents & Legal
- Personalized Medicine
- Process Development
- Product Licensing/Acquisition
- Product Recalls/Warning Letters
- Quality Management Systems
- R&D Changes & Trends
- Random Fun Stuff
- Raw Material Detectives
- Raw Material Testing
- Regenerative Medicine & Stem Cells
- Regulatory Affairs & Policy
- Risk Mitigation
- RNAi therapeutics
- Russia News
- Science & Technology
- Supply Chain Management
- Trade Policy
- Trade Shows, Seminars, & Webinars
- Translational Medicine
- Vaccines & Virus
- Venture Capital
- Virtual Biotech's
- Weblogs & Websites
- Whitepapers
Comments